The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC

Otolaryngology - Head and Neck Surgery (United States)

Volumn 142, Issue 5, 2010, Pages 753-759

  Dohadwala, Mariam ^a,b,e   Wang, Guanyu ^a,b   Heinrich, Eileen ^a,b   Luo, Jie ^a,b   Lau, Ontario ^c   Shih, Hubert ^c   Munaim, Qahera ^c   Lee, Gina ^a,b,e   Hong, Longsheng ^a   Lai, Chi ^a   Abemayor, Elliot ^c,d   Fishbein, Michael C ^a   Elashoff, David A ^a   Dubinett, Steven M ^a,b,d,e   St John, Maie A ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Pulmonary and Critical Care Medicine   (United States)

^c Division of Head and Neck Surgery   (United States)

^d Department of Biostatistics ^*  (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1BETA; RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UVOMORULIN; ZEB1 PROTEIN; CADHERIN; INTERLEUKIN 1BETA;

ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; E BOX ELEMENT; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOLECULAR BIOLOGY; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; TUMOR DIFFERENTIATION; UPREGULATION; WESTERN BLOTTING; EPITHELIUM CELL; GENETICS; HEAD AND NECK TUMOR; IMMUNOPRECIPITATION; MESODERM; METABOLISM; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLOOXYGENASE 2; EPITHELIAL CELLS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INFLAMMATION; INTERLEUKIN-1BETA; MESODERM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTION FACTORS;

EID: 77951929696     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1016/j.otohns.2010.01.034     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 40372904)
2. Zender CA, Petruzzelli GJ. Why do patients with head and neck squamous cell carcinoma experience distant metastases: can they be prevented? Curr Opin Otolaryngol Head Neck Surg 2005;2:101-4. (Pubitemid 40388252)
3. Li Y, St. John MA, Zhou X, et al. Salivary transciptome diagnostics for oral cancer detection. Clin Cancer Res 2004;10:8442-50. (Pubitemid 40053408)
4. Lin DT, Subbaramaiah K, Shah JP, et al. Cylooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 2002;8:792-9. (Pubitemid 34857307)
5. Endo T, Ogushi F, Sone S, et al. Induction of cyclooxygenase-2 is responsible for interleukin-1 beta-dependent prostaglandin E2 synthesis by human lung fibroblasts. Am J Respir Cell Mol Biol 1995;12: 358-65.
6. Dohadwala M, Yang SC, Luo J, et al. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E (2) induces transcriptional repressors ZEB1 and Snail in non-small cell lung cancer. Cancer Res 2006;66:5338-45. (Pubitemid 43844959)
7. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007;7:415-28. (Pubitemid 46809165)
8. Chow V, Yuen AP, Lam KY, et al. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma. J Cancer Res Clin Oncol 2001;127:59-63.
9. Fontemaggi G, Gurtner A, Damalas A, et al. DeltaEF1 repressor controls selectively p53 family members during differentiation. Onco-gene 2005;24:7273-80. (Pubitemid 41622231)
10. Haddad Y, Choi W, McConkey DJ. Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor Erlo-tinib in human head and neck squamous cell carcinoma lines. Clin Cancer Res 2009;15:532-42.
11. Zhang X, Chen ZG, Choe MS, et al. Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclo-oxygenase-2 in a xenograft model. Clin Cancer Res 2005;11:6261-9. (Pubitemid 41262957)
12. Hoteiya T, Hayashi E, Satomura K, et al. Expression of E-cadherin in oral cancer cell lines and its relationship to invasiveness in SCID mice in vivo. J Oral Pathol Med 1999;28:107-11. (Pubitemid 29101031)
13. Sarantopoulos GP, Gui D, Shintaku P, et al. Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation. Arch Pathol Lab Med 2004;128:406-14. (Pubitemid 38451127)
14. Krysan K, Merchant FH, Zhu L, et al. COX-2 dependent stabilization of surviving in non-small cell lung cancer. FASEB J 2004;18:206-8.
15. St. John MA, Dohadwala M, Luo J, et al. Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res 2009;15:6018-27.
16. Wolf JS, Chen Z, Dong G, et al. IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 2001;7:1812-20. (Pubitemid 32708653)
17. Chen Z, Colon I, Ortiz N, et al. Effects of interleukin-1alpha, inter-leukin-1 receptor antagonist, and neutralizing antibody on proinflam-matory cytokine expression by human squamous cell carcinoma lines. Cancer Res 1998;58:3668-76. (Pubitemid 28376567)
18. Cheng CW, Wu PE, Yu JC, et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2001;20:3814-23.